# alz_platform

**AI-driven orchestration platform for Alzheimer's research.**

Submitted to the Gates Foundation Alzheimer's Prize. This platform integrates multimodal data (clinical, imaging, omics) with validation-first pipelines to accelerate discovery and inform future trials.

## Overview

alz_platform applies the same validation-first principles used in enterprise AI systems to medical research. Every AI output is treated as provisional until validated through multiple layers of verification.

## Key Features

- **Multimodal data integration** – Clinical, imaging, and omics data unified in a single pipeline
- **Validation-first pipelines** – All AI outputs verified before use in downstream analysis
- **Cross-disciplinary AI analysis** – Multiple specialized models coordinated through orchestration layer
- **Resilient outlier detection** – Statistical methods designed for small, heterogeneous datasets
- **Protocol card generation** – Structured outputs for informing future trial design

## Architecture
```
├── api/              # API endpoints
├── cli/              # Command line interface
├── core/             # Core platform logic
├── data/             # Data handling and processing
├── docs/             # Documentation
├── med_stack/        # Medical domain modules
├── orchestration/    # Multi-agent coordination
├── schemas/          # Data schemas and validation
├── tests/            # Test suite
├── validators/       # Validation layer
```

## Philosophy

This project applies lessons from enterprise governance to medical AI:

- Outputs are unsafe until validated
- Validation is non-optional and always on
- Every decision is traceable and auditable

For more on this approach, see [The Validation-First Manifesto](https://medium.com/@AIByDean/the-validation-first-manifesto-200d45f2e898).

## Author

Edward Dean Brown  
Founder, Purple Hedgehog AI  
[LinkedIn](https://www.linkedin.com/in/edward-dean-brown-14946939) | [Medium](https://medium.com/@AIByDean)
